Table 3.
Serum Immunoglobulin (Ig) levels (number of subjects evaluated)1 | High level | Normal level | Low level | On IVIG (cannot evaluate) |
---|---|---|---|---|
IgG (34) | 2 (6%) | 32 (94%) | 0 (0%) | 10 |
IgA levels (44) | 10 (23%) | 30 (68%) | 4 (9%) | |
IgM levels (44) | 4 (9%) | 30 (68%) | 10 (23%) | |
IgE levels (44) | 9 (20%) | 32 (73%) | 3 (7%) | |
Tetanus titers1 | Normal | Low | Not tested | On IVIG (cannot evaluate) |
24 (100%) | 0 (0%) | 10 | 10 | |
Isohemagglutinins2 (number of subjects evaluated) | Normal | Low | absent | |
Anti A (18) | 7 (39%) | 10 (56%) | 1 (6%) | |
Anti B (25) | 13 (52%) | 6 (24%) | 6 (24%) |
Numbers tested are based on the most recent data point for all subjects who are alive past 6 months (n=42) plus the 2 subjects who died after 1 year (total = 44)
Numbers tested are based on all subjects who have data over 2 years after transplantation. Anti-A data are for all subjects who are not blood type A and did not receive an A thymus. Anti-B data are for all subjects who are not blood type B and did not receive a B thymus. A total of 30 subjects are included in these isohemagglutinin studies.